Aplicação tópica de lipossomas contendo cetuximabe: efeito do uso de métodos físicos de penetração cutânea no carcinoma celular escamoso de pele

Aplicação tópica de lipossomas contendo cetuximabe: efeito do uso de métodos físicos de penetração cutânea no carcinoma celular escamoso de pele

O carcinoma de células escamosas (SCC) é um tumor maligno de origem epitelial no qual o receptor de fator de crescimento epidermal (EGFR) está superexpresso e associado a malignização. O cetuximabe é um anticorpo monoclonal, capaz de se ligar seletivamente ao EGFR. A combinação de cetuximabe com o q...

Full description

Bibliographic Details
Main Author:	Petrilli, Raquel
Other Authors:	Lee, Robert
Format:	Others
Language:	pt
Published:	Biblioteca Digitais de Teses e Dissertações da USP 2017
Subjects:	5-fluorouracil Câncer de pele Carcinoma celular escamoso Cetuximab Cetuximabe Immunoliposome Imunolipossoma Liposome Lipossoma Skin cancer Squamous cell carcinoma
Online Access:	http://www.teses.usp.br/teses/disponiveis/60/60137/tde-03052017-160905/

Similar Items

<it>Let-7</it> miRNA-binding site polymorphism in the <it>KRAS</it> 3<sup>′</sup>UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
by: Kjersem Janne B, et al.
Published: (2012-11-01)

Lipossomas e imunolipossomas contendo fármacos antitumorais: desenvolvimento, caracterização e avaliação da eficácia contra o câncer de mama
by: Josimar de Oliveira Eloy
Published: (2016)

Lipossomas e imunolipossomas contendo fármacos antitumorais: desenvolvimento, caracterização e avaliação da eficácia contra o câncer de mama
by: Eloy, Josimar de Oliveira
Published: (2016)

Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study
by: Satoshi Dote, et al.
Published: (2018-10-01)

Unprecedented Simultaneous and Rapid Reversal of Oral and Alimentary Mucositis using Polymerized Cross Linked Sucralfate: Two Case Reports
by: Ricky Wayne McCullough
Published: (2014-12-01)

First-line chemotherapy for head and neck squamous cell carcinoma. Optimal strategy
by: L. V. Bolotina, et al.
Published: (2019-01-01)

Surgical resection for a huge recurrent right colon carcinoma after cetuximab plus FOLFIRI
by: Chou-Chen Chen, et al.
Published: (2021-10-01)

Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
by: Alessandra Chen, et al.
Published: (2018-01-01)

Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy
by: Seber S, et al.
Published: (2016-02-01)

Complete response with fluorouracil and irinotecan with a BRAFV600E and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report
by: Wang Z, et al.
Published: (2019-01-01)

Successful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue
by: Yasuyuki Asada, et al.
Published: (2021-07-01)

PUM1 Is Overexpressed in Colon Cancer Cells With Acquired Resistance to Cetuximab
by: Qizhi Liu, et al.
Published: (2021-08-01)

Incidence and risk factors of hypomagnesemia in head and neck cancer patients treated with cetuximab
by: Tomohiro Enokida, et al.
Published: (2016-09-01)

Organizing pneumonia secondary to cetuximab in a patient with colorectal cancer
by: Abdulaziz AlGhulayqah, et al.
Published: (2019-09-01)

Combination treatment with cetuximab in advanced nasopharyngeal carcinoma patients: a meta-analysis
by: Shen J, et al.
Published: (2019-04-01)

FR-Nueva evidencia a favor de 5-fluorouracilo en el tratamiento de las queratosis actínicas
by: D. Morgado-Carrasco, et al.
Published: (2021-01-01)

Frecuencia de metástasis a la glándula submandibular en pacientes con carcinomas escamosos de cavidad bucal
by: Rafael Michel Coca Granado, et al.

Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer
by: Muge Akmansu, et al.
Published: (2010-12-01)

Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
by: Greg Knutzen, et al.
Published: (2015-11-01)

Avaluació preclínica de l'efecte antitumoral de cetuximab sobre la malaltia microscòpica residual post-radioteràpia
by: Pueyo Castells, Gemma
Published: (2010)

Tracheal cancer treated with a short course of external and endoluminal radio-chemotherapy combined with cetuximab – a case report
by: Michael I. Koukourakis, et al.
Published: (2010-01-01)

Avaliação do potencial de nanodispersões de cristal líquido funcionalizadas com cetuximabe na veiculação de docetaxel para o tratamento do câncer de próstata /
by: Trevizan, Lucas Noboru Fatori
Published: (2018)

Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma
by: Xiqing Li, et al.
Published: (2018-07-01)

Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells
by: S. Zhang, et al.
Published: (2017-11-01)

Primary sebaceous gland carcinoma of the bulbar conjunctiva without involvement of eyelid: A clinical dilemma
by: Kalpana Pandey, et al.
Published: (2011-01-01)

Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway
by: Xuejing Zou, et al.
Published: (2016-08-01)

Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer
by: I. Grivicich, et al.
Published: (2001-09-01)

Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
by: Luigi Bennardo, et al.
Published: (2021-06-01)

Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial
by: Bekaii-Saab, T., et al.
Published: (2022)

Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen
by: Mengping Zhang, et al.
Published: (2020-06-01)

Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
by: Kunal eSaigal, et al.
Published: (2014-06-01)

Cetuximab-Induced MET Activation Acts as a Novel Resistance Mechanism in Colon Cancer Cells
by: Na Song, et al.
Published: (2014-04-01)

Cetuximab in first line treatment of metastatic colorectal cancer
by: Carlo Barone, et al.
Published: (2012-07-01)

Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice?
by: Giuliani Jacopo, et al.
Published: (2014-04-01)

Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséquence sur la pharmacocinétique et l’efficacité anti‐tumorale de médicaments substrats de ABCB1
by: Chu, Céline
Published: (2013)

Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers
by: Wing-Lok Chan, et al.
Published: (2014-01-01)

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
by: Shinya Uozumi, et al.
Published: (2018-12-01)

Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp
by: Uwe Wollina, et al.
Published: (2011-12-01)

Clinical Observation of mXELIRI and mFOLFIRI Combined with Cetuximab in First-line Treatment of Metastatic Left-side Colon Cancer
by: CHENG Jianping, et al.
Published: (2020-07-01)

Management of Two Cases of Recurrent Anal Carcinoma
by: Eiko Klimant, et al.
Published: (2013-09-01)

Cannot write session to /tmp/vufind_sessions/sess_l5b48mcre823nungjq2h0qakuf